Junior Lelio de Souza Sells Afya Limited Shares
Afya Limited's Vice President sold over 41,500 shares, totaling $623,115.
Key Points
- Junior Lelio de Souza, Afya Limited's Vice President, sold 41,541 shares on June 26, 2026, for $623,115.
- Afya Limited, trading at $14.87 on Wednesday, has a market cap of about $1.36 billion and a P/E ratio of 9.29.
- Analysts have set a mean price target of $16.55 for Afya, with recent downgrades from B of A Securities and Morgan Stanley.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Junior Lelio de Souza, a Vice President at Afya Limited, sold 41,541 shares of the company on June 26, 2026. The shares were sold at an average price of $15.00 each, totaling approximately $623,115. This transaction was not part of a pre-planned stock sale program.
Insider Buying and Selling at Afya Limited
Junior Lelio de Souza's recent sale is one of several insider transactions at Afya Limited. On the same day, Vice President Basolli Gomiero Mirella sold 10,000 shares at $14.80 each. Earlier, on May 7, 2026, CEO Virgilio Deloy Capobianco Gibbon purchased 59,000 shares, while Vice President Coelho Ribeiro Erico sold 10,200 shares.
Afya Limited Stock Up 1.6%
Shares of NasdaqGS:AFYA traded near $14.87 on Wednesday. Afya Limited, a Brazilian medical education group, boasts a market cap of approximately $1.36 billion. The stock has a P/E ratio of 9.29 and a beta of 0.365, indicating relatively low volatility. Its 52-week range spans from $13.00 to $18.16, with a 50-day moving average of $14.35 and a 200-day moving average of $14.67.
$AFYA stock price
Daily closing prices, year to date. Not investment advice.
Analysts Set New Price Targets
On June 22, 2026, JP Morgan maintained a 'hold' rating for Afya Limited with a price target of $21.00. Earlier in the year, B of A Securities downgraded the stock to 'hold' with a $17.00 target, while Morgan Stanley set a 'sell' rating with a $16.00 target. The consensus among analysts is an 'underperform' rating, with a mean target price of $16.55.
About Afya Limited
Afya Limited, headquartered in Belo Horizonte, Brazil, operates as a medical education group. It offers undergraduate and continuing education programs, and medical practice solutions. The company is led by CEO Virgilio Deloy Capobianco Gibbon and employs nearly 9,400 people. Afya's educational services span various health and non-health fields, and it provides digital tools for medical professionals.
Bottom Line
Junior Lelio de Souza's recent sale of Afya Limited shares is one of several insider transactions this year. Investors closely watch such moves for potential signals about a company's prospects. While insider sales can raise questions, they are not uncommon and may not reflect the company's current standing. As always, it's important to consider the broader market context and individual investment goals.
Get Afya Limited alerts
New 13F filings, insider trades, and analyst moves on $AFYA, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.